September 29, 2016 5:53 AM ET

Life Sciences Tools and Services

Company Overview of Nabsys 2.0 LLC

Company Overview

Nabsys 2.0 LLC develops semiconductor-based tools for genomic analysis. It offers semiconductor-based nanodetectors to analyze long DNA molecules electronically. Its technology allows researchers and clinicians to draw conclusions about DNA. Nabsys 2.0 LLC was formerly known as NABsys, Inc. The company was founded in 2004 and is based in Providence, Rhode Island.

60 Clifford Street

Providence, RI 02903

United States

Founded in 2004

Phone:

401-276-9100

Fax:

401-276-9122

Key Executives for Nabsys 2.0 LLC

Co-Founder, Chief Executive Officer and Director
President and Director
Age: 60
Co-Founder and Sab Member
Chief Financial Officer
Executive Vice President of Product Development
Compensation as of Fiscal Year 2016.

Nabsys 2.0 LLC Key Developments

Nabsys and Ariana Pharma Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers

Nabsys, Inc., and Ariana Pharmaceuticals SA, announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and breast cancers and to the clinical outcome of patients with these diseases through the analysis of public genome databases. Through the partnership, the two companies will develop a single database each for the analysis of Prostate Adenocarcinomas and for the analysis of Breast Cancer. The generation of two signatures comprised of previously-identified DNA structure variations will improve individual predictive capabilities and will ultimately be employed in personalize treatment plans. The ability to demonstrate links between SVs and Progression Free Survival (PFS) and Overall Survival (OS) end-points goes well beyond the current commercial offerings for small segment sequencing.

NABsys, Inc. Appoints Anthony Shuber as Vice President and Chief Scientific Officer

NABsys, Inc. announced that Anthony Shuber has joined the company as Vice President and Chief Scientific Officer. In this role, Shuber will lead the company's efforts in product strategy as the company transitions its initial commercial focus toward oncology. Shuber, an industry veteran and accomplished inventor, has over 24 years of experience in developing commercial diagnostics and research and applied genomics products and holds 50 patents.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 21, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nabsys 2.0 LLC, please visit www.nabsys.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.